Fate Therapeutics FATE
NASDAQ FATE
$1.61 -0.16 (-9.32%)
At close: Nov 11, 2026 · 4:00 PM EST

Fate Therapeutics (FATE) Return on Assets [ROA] (2013 - 2026)

Updated

Fate Therapeutics (FATE) recorded Return on Assets [ROA] of -46.01% in Q2 2026, up 0.16 percentage points from -46.16% a year earlier but down 3.00 percentage points from the prior quarter.

Analysis

Fate Therapeutics (FATE) Return on Assets [ROA] (2013 - 2026) Analysis & Trends

For FY2025, Fate Therapeutics reported Return on Assets [ROA] of -35.98%, up 4.78 percentage points from FY2024.

  • Annual Return on Assets [ROA] has a five-year change of -8.80 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Assets [ROA] came in at -40.76% in FY2024 (-12.15 pp), -28.61% in FY2023 (+8.58 pp), -37.19% in FY2022 (-9.25 pp) and -27.94% in FY2021 (-0.76 pp).
  • Quarterly Return on Assets [ROA] has ranged from -46.16% in Q2 2025 to -17.96% in Q3 2021 over the past five years.
  • On a year-over-year basis, Return on Assets [ROA] rose in two of the last eight quarters, with an average year-over-year change of -5.01 percentage points.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 8.58 percentage points in Q4 2023, against a drop of 21.88 percentage points in Q3 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -43.00% (Q1 2026), -41.25% (Q4 2025) and -45.30% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Fate Therapeutics 215.18 Mn 76.08 Mn - -50.06%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -50.06%
Jun 30, 2026 -46.30%
Mar 31, 2026 -43.11%
Dec 31, 2025 -41.19%
Sep 30, 2025 -43.83%
Jun 30, 2025 -44.41%
Mar 31, 2025 -41.82%
Dec 31, 2024 -39.76%
Sep 30, 2024 -34.56%
Jun 30, 2024 -31.96%
Mar 31, 2024 -35.24%
Dec 31, 2023 -30.30%
Sep 30, 2023 -30.20%
Jun 30, 2023 -34.36%
Mar 31, 2023 -34.84%
Dec 31, 2022 -38.88%
Sep 30, 2022 -38.19%
Jun 30, 2022 -30.86%
Mar 31, 2022 -26.45%
Dec 31, 2021 -22.35%
API Access

Fate Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=FATE&period=max&api_key=YOUR_API_KEY